Alkylating Agent-Related Acute Myeloid Leukemia

Explore clinical trials studying Alkylating Agent-Related Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

14 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Alkylating Agent-Related Acute Myeloid Leukemia trial results

Completed

NCT00217646

Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia, +52 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Completed

NCT01361464

Conditions: Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +26 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States

Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

Completed

NCT01132586

Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, +19 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

Active, Not Recruiting

NCT01627041

Conditions: Acute Myeloid Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Monoblastic Leukemia, +17 more
Locations: Lafayette Family Cancer Center-EMMC Brewer, Maine, United States

Roswell Park Cancer Institute Buffalo, New York, United States

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States

Memorial Sloan Kettering Cancer Center New York, United States